Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
AtriCure Inc
F:A5I
AtriCure Inc
F:A5I
Price:
59.5
EUR
0.85%
Market Cap:
€3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
AtriCure Inc
F:A5I
|
US |
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
Central Pattana PCL
SET:CPN
|
TH |
Wall St Price Targets
A5I Price Forecast
Based on 11 analysts
Based on 11 analysts
-44% Downside
from
€59.5
today
AtriCure Inc (A5I)’s 12-month stock price forecast through September 2022 has a consensus target of €33.15, implying 44% downside. The forecast is based on price targets from 11 Wall Street analysts.
A5I Analyst Rating
No ratings yet
No ratings yet
AtriCure Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A5I's stock price target?
Price Target
33.15
EUR
33.15
EUR
According to Wall Street analysts, the average 1-year price target for A5I is 33.15 EUR with a low forecast of 28.66 EUR and a high forecast of 36.84 EUR.
What is the Revenue forecast for AtriCure Inc?
Projected CAGR
14%
14%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 14%.
What is the Gross Profit forecast for AtriCure Inc?
Projected CAGR
14%
14%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 6 years is 14%.